A rendering of the Lithoplasty balloon catheter, screenshot--Courtesy of Shockwave Medical Medical device makers are scrambling to develop and sell advanced angioplasty balloons to treat peripheral ...

A rendering of the Lithoplasty balloon catheter, screenshot--Courtesy of Shockwave Medical Startup Shockwave Medical expects that its Lithoplasty balloon catheters will emerge as a pretreatment for ...

“Cutting balloon angioplasty is a reasonable and less costly option when compared with intravascular lithotripsy for the ...

SANTA CLARA, Calif., Nov. 07, 2020 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat severely ...

Shockwave Medical, Inc. (“Shockwave”) owns U.S. Patent No. 8,956,371 (“the ’371 patent”). This patent is directed to the treatment of atherosclerosis through intravascular lithotripsy (“IVL”). The ...

SANTA CLARA, Calif., May 19, 2022 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular ...

Johnson & Johnson (J&J) MedTech’s Shockwave Medical has launched the E⁸ peripheral intravascular (IVL) catheter in the US for patients living with certain types of peripheral artery disease (PAD).

Dr. Andrew Hearn, an endovascular surgeon with Mercy Health-Cincinnati, is testing new technology at West Hospital to care for patients with a condition that puts people at risk for losing limbs or ...

The Federal Circuit recently issued a precedential decision in Shockwave Med., Inc. v. Cardiovascular Sys., Inc. (CSI), affirming-in-part and reversing-in-part the Patent Trial and Appeal Board’s ...

ShockWave Medical makes devices used to break up calcium deposits that can damage blood vessels. Its proprietary devices use sound waves and there aren't any competitors in this niche. The devices ...

Despite doubling over a two-month period, this high-growth stock has given back most of its gains. What should investors think? While shares of the company have more than doubled over a two-month ...